|
This week is National Influenza Immunization Week (NIVW), a timely reminder that it's not too late to protect yourself and your loved ones against the flu.The CDC recommends everyone 6 months and older get their flu vaccine annually to reduce the risk of illness, missed work or school, and serious complications.
For more information, please visit the CDC's website.
Did you miss our recent virtual training?
The recording is now available for viewing at your convenience.
This training was designed to equip providers with essential immunization knowledge, including the latest programmatic updates to keep you informed and prepared.
Access the Recording Here.
We have received several inquiries from providers regarding the proper procedure for handling expired or wasted COVID-19 vaccines. We'd like to remind providers that, the Maine Immunization Program (MIP) requires all unopened or unused vials and syringes of expired MIP-supplied
vaccines be returned to the third-party distributor (McKesson).
For more information on vaccine returns and proper storage and handling practices, please refer to Maine Immunization Program
Provider Policy and Procedure Manual.
Staff must follow the procedures listed below when a vaccine loss occurs:
- Remove expired or spoiled vaccine from the vaccine storage unit
and mark "DO NOT USE".
- Reconcile the vaccine loss in ImmPact.
- Contact MIP’s Vaccine Management (207-287-3006) for a return authorization.
If you have any questions or need assistance with the return process, please feel free to reach out.
As MIP continues to receive additional allocations from the Center for Disease Control and Prevention (CDC), ordering for nirsevimab will remain open each week allowing provider sites to order the number of doses needed to accommodate their patient population throughout the Respiratory Syncytial Virus (RSV) season.
-
Nirsevimab 50 mg remains available to order at a maximum quantity of 50 doses per site.
-
Nirsevimab 100 mg remains open at 75 doses per site.
**All orders for nirsevimab MUST be placed separate from regular vaccine orders.
|
**McKesson's Holiday Shipping Calendar**
If you are expecting orders to arrive before the holidays, please keep in mind that routine shipments from McKesson can take up to 4 business days to process before they are shipped. Also, note that shipments may take longer than 4 days to process and ship if the provider does not have regular business hours daily (Regular hours are defined as M-F, 8am-5pm).
Providers are strongly encouraged to order early during the winter holidays. Providers are also encouraged to maintain a minimum of 4 weeks of inventory to prevent vaccine outages if orders are delayed due to weather and/or carrier interruptions.
VBI Vaccines, the manufacturer of its HepB vaccine, PreHevbrio, is ending business operations. PreHevbrio will no longer be distributed. Customers with the product are asked to dispose of or return remaining doses. The recall is not related to vaccine safety or quality. All properly administered doses of PreHevbrio are valid HepB vaccinations and do not need to be repeated.
If you have PreHevbrio or have questions about it, visit the PreHevbrio website for additional information and guidance.
Adults with an incomplete PreHevbrio vaccination series can complete their series with Heplisav-B, Engerix-B, or Recombivax-HB. For a guide to completing a mixed-product vaccination series, see the table in Immunize.org’s Ask the Experts: Can You Show the Options of How to Complete Adult Hepatitis B Vaccination with Different Vaccine Products?
This message is to inform you of the FluMist Replacement Program for product purchased through the Childhood Vaccine Program. The Replacement Program allows for the replacement of unused, expiring FluMist doses, at no cost, to help you maximize product usage opportunities. AstraZeneca has contracted with McKesson Specialty Health (MSH) for implementation of this Replacement Program. This contract is between AstraZeneca and McKesson.
If providers would like to take advantage of this replacement program, they can contact the AstraZeneca Replacement Program by phone or by email, as detailed in the instructions included. PDF version available here.
Eligibility Guidelines are described below, and requests for replacements can be made between Monday, December 2, 2024 and Friday, January 31, 2025 by 7:00 pm CST (5:00 pm PST)
- Doses must have been purchased on the CDC contract. Private doses are not eligible for the FluMist® Trivalent Replacement Program for CDC.
- Product expiration date must be on or before February 2, 2025.
- AstraZeneca will replace expired doses of FluMist® while supplies last.
Requests can be made until Friday, January 31, 2025, at 7 p.m. CST.
For more information, please contact the FluMist® Replacement Program for CDC by e‐mail (flumistreplacement@mckesson.com) or
phone (1‐877‐633‐7375) |
